Skip to content
healthcare.dev

Irinotecan hydrochloride

NDC 45963-614, Irinotecan hydrochloride, injection, solution, from Actavis Pharma, Inc..

Product NDC
45963-614
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078589
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45963-614 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
45963-614-51459630614511 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-51) / 2 mL in 1 VIAL, SINGLE-DOSE
45963-614-55459630614551 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-55) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5e1fdcaa-918f-4cd8-9c7a-4c538d866198
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=45963-614

Use it

Look up 45963-614 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45963-614 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45963-614. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.